KRYS Krystal Biotech PE ratio, current and historical analysis
As of Mar 14, 2025, the KRYS stock has a PE ratio of 57.49. The calculation is based on the latest EPS of $3.12 and the stock price of $179.38 per share. A decrease of 20% has been observed in the PE ratio compared to its average of 71.9 of the last four quarters.
KRYS PE ratio history
The mean historical PE ratio of Krystal Biotech over the last eight years is 99.69. The current 57.49 P/E ratio is 42% lower than the historical average. Looking back at the last eight years, KRYS's PE ratio peaked in the Dec 2023 quarter at 310.15, with a price of $124.06 and an EPS of $0.4. The Sep 2017 quarter marked the lowest point at 0.27, with a price of $9.97 and an EPS of $37.27.
Krystal Biotech PE ratio by year
Maximum annual decrease: -83.81% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 50.21 | -83.81% | $156.66 | $3.12 |
| 2023 | 310.15 | N/A | $124.06 | $0.4 |
| 2022 | N/A | N/A | $79.22 | -$5.49 |
| 2021 | N/A | N/A | $69.95 | -$3.13 |
| 2020 | N/A | N/A | $60 | -$1.71 |
| 2019 | N/A | N/A | $55.38 | -$1.2 |
| 2018 | N/A | N/A | $20.78 | -$0.97 |
| 2017 | N/A | N/A | $10.52 | -$1.48 |
| 2016 | N/A | N/A | N/A | -$1.31 |
Krystal Biotech PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 50.21 | -49.25% | $156.66 | $3.12 |
| Sep 2024 | 98.93 | 103.1% | $182.03 | $1.84 |
| Jun 2024 | 48.71 | -45.79% | $183.64 | $3.77 |
| Mar 2024 | 89.86 | -71.03% | $177.93 | $1.98 |
| Dec 2023 | 310.15 | N/A | $124.06 | $0.4 |
| Sep 2023 | N/A | N/A | $116 | -$1.38 |
| Jun 2023 | N/A | N/A | $117.4 | -$5.43 |
| Mar 2023 | N/A | N/A | $80.06 | -$5.28 |
| Dec 2022 | N/A | N/A | $79.22 | -$5.49 |
| Sep 2022 | N/A | N/A | $69.7 | -$5.21 |
| Jun 2022 | N/A | N/A | $65.66 | -$4.74 |
| Mar 2022 | N/A | N/A | $66.54 | -$4.38 |
| Dec 2021 | N/A | N/A | $69.95 | -$3.13 |
| Sep 2021 | N/A | N/A | $52.21 | -$2.71 |
| Jun 2021 | N/A | N/A | $68 | -$2.5 |
KRYS average PE ratio chart
The current PE ratio of KRYS is lower than its 3 and 5-year averages.
KRYS PE vs peers
In comparison to its peer stock ORMP, KRYS's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ORMP Oramed Pharmaceuticals Inc | 21.73 | $96.35M |
| KRYS Krystal Biotech Inc | 57.49 | $5.17B |
| OLMA Olema Pharmaceuticals Inc | N/A | $252.68M |
| OMER Omeros Corp | N/A | $487.94M |
| ONVO Organovo Holdings Inc | N/A | $7.4M |
| ORIC Oric Pharmaceuticals Inc | N/A | $553.3M |
Frequently asked questions
What is Krystal Biotech's PE ratio?
KRYS stock has a price to earnings ratio of 57.49 as of Mar 14, 2025.
What is the 3-year average PE ratio for Krystal Biotech (KRYS)?
As an average over the last 3 years, KRYS stock has a PE ratio of 119.57.
What is the 5-year average PE ratio for Krystal Biotech (KRYS)?
As an average over the last 5 years, KRYS stock has a PE ratio of 119.57.
What is the highest PE ratio for KRYS?
Over the last eight years, the Dec 2023 quarter recorded the highest quarterly PE ratio at 310.15.
How does the current PE ratio for KRYS compare to its historical average?
KRYS's current price to earnings ratio is 42% below its 8-year historical average.
How is KRYS's PE ratio calculated (Krystal Biotech PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Mar 14, 2025), Krystal Biotech's share price is $179.38. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $3.12. Therefore, Krystal Biotech's PE ratio for today is 57.49. PE RATIO(57.49) = STOCK PRICE($179.38) / TTM EPS($3.12)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.